Figure 4From: Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study Fecal occult blood after two weeks’ treatment with irsogladine or omeprazole compared to baseline. Back to article page